Champlain Investment Partners, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Champlain Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $30.2 Million - $43.5 Million	-1,160,460 Reduced 32.39%	2,422,070 $68.8 Million
Q1 2022 May 12, 2022	BUY	$24.46 - $40.92 $694,786 - $1.16 Million	28,405 Added 0.8%	3,582,530 $126 Million
Q4 2021 Feb 10, 2022	BUY	$35.0 - $45.94 $9.46 Million - $12.4 Million	270,304 Added 8.23%	3,554,125 $149 Million
Q3 2021 Nov 12, 2021	SELL	$36.8 - $60.62 $6.32 Million - $10.4 Million	-171,804 Reduced 4.97%	3,283,821 $161 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $45.0 $56.7 Million - $78.6 Million	1,746,410 Added 102.18%	3,455,625 $144 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $44.1 Million - $65.8 Million	1,709,215 New	1,709,215 $60.9 Million

226

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $648M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.